New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Deciphering progesterone's mechanisms of action in breast cancer

Deciphering progesterone's mechanisms of action in breast cancer

by Impact Journals LLCAn integrated representation of the multifaceted effects of progesterone in breast cancer. A schematic representation to describe the molecular mechanisms by which progesterone a
World medicine December 10,2023
Deciphering progesterone's mechanisms of action in breast cancer

Deciphering progesterone's mechanisms of action in breast cancer

by Impact Journals LLCAn integrated representation of the multifaceted effects of progesterone in breast cancer. A schematic representation to describe the molecular mechanisms by which progesterone a
World medicine December 10,2023
Gains in colorectal cancer outcomes slowing, reversing

Gains in colorectal cancer outcomes slowing, reversing

by Lori SolomonDecreases in colorectal cancer (CRC) diagnoses and deaths among adults in their 50s and 60s have slowed compared with previous decades, according to a study recently published inC
World medicine December 10,2023
Gains in colorectal cancer outcomes slowing, reversing

Gains in colorectal cancer outcomes slowing, reversing

by Lori SolomonDecreases in colorectal cancer (CRC) diagnoses and deaths among adults in their 50s and 60s have slowed compared with previous decades, according to a study recently published inC
World medicine December 10,2023
Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

by Liana F. Wait,University of PennsylvaniaInhibiting the enzyme NOTUM slowed cancer growth and prevented metastasis in an animal model of colorectal cancer. Credit: Yuhua TianColorectal cancer
World medicine December 10,2023
Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

by Liana F. Wait,University of PennsylvaniaInhibiting the enzyme NOTUM slowed cancer growth and prevented metastasis in an animal model of colorectal cancer. Credit: Yuhua TianColorectal cancer
World medicine December 10,2023
Colorectal cancer patients may benefit from breakthrough EU research

Colorectal cancer patients may benefit from breakthrough EU research

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: Pixabay/CC0 Public DomainScientists in Spain have developed a potentially life-saving strategy against a disease that sp
World medicine December 10,2023
Colorectal cancer patients may benefit from breakthrough EU research

Colorectal cancer patients may benefit from breakthrough EU research

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: Pixabay/CC0 Public DomainScientists in Spain have developed a potentially life-saving strategy against a disease that sp
World medicine December 10,2023
Combining epigenetic and metabolic approaches for targeted cancer treatment

Combining epigenetic and metabolic approaches for targeted cancer treatment

by Olivia Dimmer,Northwestern UniversityCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI169993Northwestern Medicine scientists have identified a novel vulnerability i
World medicine December 10,2023
Combining epigenetic and metabolic approaches for targeted cancer treatment

Combining epigenetic and metabolic approaches for targeted cancer treatment

by Olivia Dimmer,Northwestern UniversityCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI169993Northwestern Medicine scientists have identified a novel vulnerability i
World medicine December 10,2023
Outcome indicators make quality of life after childhood cancer measurable

Outcome indicators make quality of life after childhood cancer measurable

by Princess Máxima Center for Pediatric OncologyInternational Childhood Cancer Core Outcome Set. Credit:Nature Medicine(2023). DOI: 10.1038/s41591-023-02339-yA new measurement tool helps a
World medicine December 10,2023
Outcome indicators make quality of life after childhood cancer measurable

Outcome indicators make quality of life after childhood cancer measurable

by Princess Máxima Center for Pediatric OncologyInternational Childhood Cancer Core Outcome Set. Credit:Nature Medicine(2023). DOI: 10.1038/s41591-023-02339-yA new measurement tool helps a
World medicine December 10,2023
Colon cancer: Curcumin activates tumor suppressive signaling pathway

Colon cancer: Curcumin activates tumor suppressive signaling pathway

byLudwig Maximilian University of MunichTurmeric root. Credit: Pixabay/CC0 Public DomainColorectal cancer is one of the most common types of cancer worldwide. In more than half of all cases, an
World medicine December 10,2023
Colon cancer: Curcumin activates tumor suppressive signaling pathway

Colon cancer: Curcumin activates tumor suppressive signaling pathway

byLudwig Maximilian University of MunichTurmeric root. Credit: Pixabay/CC0 Public DomainColorectal cancer is one of the most common types of cancer worldwide. In more than half of all cases, an
World medicine December 10,2023
Revealing the roles of TLR7, a nucleic acid sensor for COVID-19, in pan-cancer

Revealing the roles of TLR7, a nucleic acid sensor for COVID-19, in pan-cancer

by Compuscript LtdCorrelation between TLR7 and COVID-19.A) Changes of TLR7 expression in the lungs of mice infected with SARS-CoV (GSE52920); B) TLR7-related disease network chart using Opentarg
World medicine December 10,2023
Revealing the roles of TLR7, a nucleic acid sensor for COVID-19, in pan-cancer

Revealing the roles of TLR7, a nucleic acid sensor for COVID-19, in pan-cancer

by Compuscript LtdCorrelation between TLR7 and COVID-19.A) Changes of TLR7 expression in the lungs of mice infected with SARS-CoV (GSE52920); B) TLR7-related disease network chart using Opentarg
World medicine December 10,2023
Revealing characteristics of nonparticipating individuals in breast cancer screening

Revealing characteristics of nonparticipating individuals in breast cancer screening

byUniversity of TsukubaCredit: AI-generated imageLow participation rates in cancer screening have become a concern in Japan, and breast cancer is no exception. Despite the government's objec
World medicine December 10,2023
Revealing characteristics of nonparticipating individuals in breast cancer screening

Revealing characteristics of nonparticipating individuals in breast cancer screening

byUniversity of TsukubaCredit: AI-generated imageLow participation rates in cancer screening have become a concern in Japan, and breast cancer is no exception. Despite the government's objec
World medicine December 10,2023
Uncovering why some cells become resistant to anti-cancer therapies

Uncovering why some cells become resistant to anti-cancer therapies

by Win Reynolds,Northwestern UniversityFateMap reveals that between-clone fate type diversity arises from a single cell upon therapy treatment. Credit:Nature(2023). DOI: 10.1038/s415
World medicine December 10,2023
Uncovering why some cells become resistant to anti-cancer therapies

Uncovering why some cells become resistant to anti-cancer therapies

by Win Reynolds,Northwestern UniversityFateMap reveals that between-clone fate type diversity arises from a single cell upon therapy treatment. Credit:Nature(2023). DOI: 10.1038/s415
World medicine December 10,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com